Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 656 clinical trials
Characterization of Methylation Patterns in Hepatocellular Carcinoma

This study is being performed as part of the development process of the Liver EpiCheck test which includes the identification of different methylation profiles in HCC (hepatocellular carcinoma) patients compare to cancer free control in blood samples

cirrhosis
non-alcoholic fatty liver
hepatocellular carcinoma
fatty liver
ascites
  • 0 views
  • 19 Feb, 2024
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study

It addresses an important challenge in the prevention of colorectal cancer: how to safely and effectively remove large polyps.

colorectal cancer
colorectal polyps
cancer
prevention of colorectal cancer
endoscopic resection
  • 0 views
  • 19 Feb, 2024
EsophaCap for the Detection of Early Esophageal Carcinoma

This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.

squamous cell carcinoma
early diagnosis
barrett's esophagus
esophagogastroduodenoscopy
gastric cancer
  • 0 views
  • 19 Feb, 2024
Diagnosis Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter Two-way Non-intervention Study

This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival Secondary purpose: Exploring the actual clinical treatment situation and its compliance with the …

cholangiocarcinoma
cancer
  • 0 views
  • 19 Feb, 2024
Development and Validation for Predicting Inadequate Bowel Preparation

High-quality colonoscopy is considered the gold standard for the detection and prevention of colorectal cancer, and its efficacy is predicated on optimal colon cleansing.However, about 18%-35% of patients were still reported to suffer inadequate bowel preparation.

  • 0 views
  • 19 Feb, 2024
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellular carcinoma) and for comparative purpose a cohort of subjects with diabetes and/or obesity and/or other risk factors (i.e. psoriasis, …

cirrhosis
non-alcoholic fatty liver
steatosis
fatty liver
inflammatory bowel disease
  • 0 views
  • 19 Feb, 2024
The European NAFLD Registry

The European NAFLD Registry is a prospectively recruited, observational study supporting the study of the clinical phenotype, natural history, disease outcomes and pathophysiology of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. The ultimate goals are to better understand the drivers of interpatient variation in disease pathophysiology and severity and to …

glycosylated hemoglobin
cirrhosis
type 1 diabetes mellitus
non-alcoholic fatty liver
steatohepatitis
  • 0 views
  • 19 Feb, 2024
GROWing Up With Rare GENEtic Syndromes

Introduction Rare complex syndromes Patients with complex genetic syndromes, by definition, have combined medical problems affecting multiple organ systems, and intellectual disability is often part of the syndrome. During childhood, patients with rare genetic syndromes receive multidisciplinary and specialized medical care; they usually receive medical care from 3-4 medical specialists. …

genetic disorder
congenital disorder
premature
intellectual disability
congenital disorders
  • 0 views
  • 19 Feb, 2024
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

isatuximab
refractory multiple myeloma
multiple myeloma
carcinoma
complete resection
  • 0 views
  • 19 Feb, 2024
  • 4 locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

isatuximab
refractory multiple myeloma
multiple myeloma
carcinoma
complete resection
  • 0 views
  • 19 Feb, 2024
  • 10 locations